Rohit KumarCOVID-19 Vaccine: Do We Have Enough Manufacturing Capacity?As per a recent article published in Financial Times, Sanofi has warned that Europe lacks the vaccine manufacturing capacity to cope with…Mar 29, 20201Mar 29, 20201
Rohit KumarClinical Trials During COVID-19: Time to go VirtualThe ongoing COVID-19 pandemic has been nothing short of a nightmare. As the number of infected patients approaches 400,000, there is…Mar 29, 2020Mar 29, 2020
Rohit KumarThe Treasure Hunt for Novel Biomarkers and Rise of TMBOver the years, several cancer-related biomarkers have been identified, which can be used to predict response to certain types of…Nov 4, 2019Nov 4, 2019
Rohit KumarinPharmaInsightsAducanumab has a John Snow like resurrection in the Game of Thrones for AlzheimerIn one of the most drastic shifts in fortune in the pharmaceutical industry, Biogen has decided to submit its previously failed…Oct 22, 2019Oct 22, 2019
Rohit KumarinPharmaInsightsADC Therapeutics Market: 6th World ADC Awards Unfold Key InnovatorsLast week, the eyes of all the key stakeholders in the Antibody Drug Conjugates (ADCs) space were on the developments happening in San…Oct 21, 20191Oct 21, 20191
Rohit KumarinPharmaInsightsGene Therapy Market: Big Pharma Bets BigLast week, I came across an interesting article by Andrew Dunn titled Sanofi investing in gene therapy as R&D focus turns toward rare…Oct 21, 2019Oct 21, 2019
Rohit KumarinPharmaInsightsTechnological Evolution of ADC Conjugation PlatformsLast week, I wrote an article on the key innovators in ADC therapeutics space, highlighting the key winners at the 6th World ADC Awards…Oct 21, 2019Oct 21, 2019
Rohit KumarinPharmaInsightsGene Therapy Market: A Strong Pipeline with $12 Billion Opportunity by 2030From being a thing of science fiction to topping the priority list of every big pharma player, gene therapies have come a long way. With…Oct 21, 2019Oct 21, 2019
Rohit KumarinPharmaInsightsHunt for Novel Cancer Treatment Options and Rise of T-Cell ImmunotherapiesCancer is known to be one of the leading causes of death worldwide, accounting for more than 600,000 deaths in 2018 in the US alone. As…Oct 14, 2019Oct 14, 2019
Rohit KumarinPharmaInsightsT-Cell Immunotherapies Market: KOL Interviews Highlight Key TrendsT-Cell immunotherapies have gained a lot of traction in recent years. With a plethora of clinical evidence and billions of dollars in…Oct 14, 2019Oct 14, 2019
